At some point in her life, one-third of all women experience heavy menstrual bleeding. Approximately 5 percent of
reproductive-age women in Western countries will seek treatment for menorrhagia annually. Half of all women treating for
hypermenorrhea have a uterine abnormality, most commonly fibroids (in patients under the age of 40) and endometrial polyps
(over the age of 40 years). Suitable Co-Treatment for consider improves quality of life of the patients, to have the best care
choices, it is important to make a thorough evaluation of the patient. This guideline provides instructions on how fertile-age
women who have menorrhagia can be examined and treated. The subject's own appraisal of the amount of menstrual blood loss
generally does not reflect the true amount.
